PATENT CLAIM ANALYSIS

Application Number: 16256615
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["536", "024500"]

Abstract:
Disclosed herein are methods and compositions useful in targeting a payload to, or editing a target nucleic acid, where a governing gRNA molecule is used to target, optionally inactivate, a Cas9 molecule or a Cas9 molecule/gRNA complex.

Claim (Index 1):
A gRNA molecule that targets a Cas9 molecule.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.4
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14536319', '15825616', '14644181', '15904269', '14582938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6197129968093495
- 35 USC 102 Novelty (BERT): 0.5665588938749533
- Combined Prediction Score: 0.6143975865159099
- Mean Citation Score: 373.516542
- Max Citation Score: 448.14398
- Similarity Product: 353.18590527741907

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test